SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-117657
Filing Date
2022-11-14
Accepted
2022-11-14 07:04:06
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pmn-20220930x10q.htm   iXBRL 10-Q 1432278
2 EXHIBIT 31.1 pmn-20220930xex31d1.htm EX-31.1 6904
3 EXHIBIT 31.2 pmn-20220930xex31d2.htm EX-31.2 7579
4 EXHIBIT 32.1 pmn-20220930xex32d1.htm EX-32.1 9536
  Complete submission text file 0001104659-22-117657.txt   6202131

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pmn-20220930.xsd EX-101.SCH 51364
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmn-20220930_cal.xml EX-101.CAL 41359
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmn-20220930_def.xml EX-101.DEF 132237
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20220930_lab.xml EX-101.LAB 444500
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20220930_pre.xml EX-101.PRE 324045
71 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20220930x10q_htm.xml XML 1001588
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41429 | Film No.: 221380095
SIC: 2834 Pharmaceutical Preparations